Philips announces 5,000th Zenition mobile C-arm system installation, advancing access to high-quality, efficient surgical and interventional care worldwide October 8, 2025 Global adoption milestone underscores innovation in mobile C-arm surgical and interventional imaging, with more than 15 million patients treated in 170+ countries every year Amsterdam, the Netherlands – (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the 5,000th installation of its Philips Zenition mobile surgery imaging system at Kolín Regional Hospital in the Czech Republic. Since its la...
Communiqué financier : Cession d'HEIDSIECK & C° MONOPOLE Reims, le 1er octobre 2025 Faisant suite au communiqué de presse du 24 septembre dernier, les sociétés Vranken-Pommery Monopole et LANSON-BCC ont convoqué leur Conseil d’Administration respectif afin de statuer sur le projet de cession de la société Heidsieck & C° Monopole, propriétaire de la marque éponyme. Fondée en 1785 par Florens-Louis Heidsieck la Maison Heidsieck & C° Monopole est l’une des plus anciennes Maisons de Champagne, propriété de Vranken-Pommery Monopole depuis 1996. Le Conseil d’Administ...
FINANCIAL PRESS RELEASE : SALE OF HEIDSIECK & C° MONOPOLE Reims, October 1, 2025 Following the press release of September 24, Vranken-Pommery Monopole and LANSON-BCC called their respective Boards of Directors to decide on the proposed sale of Heidsieck & C° Monopole, owner of the eponymous brand. Founded in 1785 by Florens-Louis Heidsieck, the House of Heidsieck & C° Monopole is one of the oldest Champagne Houses, owned by Vranken-Pommery Monopole since 1996. The Board of Directors of Vranken-Pommery Monopole carefully examined all offers in every aspect, in t...
Philips unveils latest CT and MR innovations in radiation therapy, advancing precision cancer care at ASTRO 2025 September 26, 2025 New Rembra RT and Areta RT [1] CT platforms drive accuracy and efficiency in radiation therapy with advanced workflows and long-term valuePhilips debuts helium-free [2] BlueSeal RT 1.5T 70cm MR system with AI-powered SmartSpeed Precise, expanding its leadership in sustainable MR for radiation oncology Amsterdam, the Netherlands – At the American Society for Radiation Oncology () 2025 Annual Meeting, (NYSE: PHG, AEX: PHIA), a global leader in health technolog...
Philips joins Optum Healthcare’s network as a preferred provider in the USA September 25, 2025 Philips’ ambulatory and diagnostic solutions and services are now available to 3.4 million Optum policyholders for enhanced outpatient cardiac monitoring Amsterdam, the Netherlands – (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that it has entered a national partnership in the USA with Optum Healthcare. The inclusion of Philips’ (MCOT) and Philips Extended Holter (ePatch) in the network is designed to enable earlier detection of cardiac conditions and timely cli...
FINANCIAL PRESS RELEASE : SALE OF HEIDSIECK & CO MONOPOLE Reims, September 24, 2025 Vranken-Pommery Monopole has entered exclusive negotiations with Lanson-BCC, acting on behalf of its subsidiary Maison Burtin, with a view to selling the shares of Heidsieck & Co Monopole (owner of the eponymous brand), excluding all other assets. Subject to the approval of the Boards of Directors of both companies, the agreement is expected to be signed on October 1, 2025. About Vranken-Pommery Monopole : Vranken-Pommery Monopole manages 2,600 hectares of land, either owned or leased, spread across fou...
COMMUNIQUE FINANCIER : CESSION D’HEIDSIECK & CO MONOPOLE Reims, le 24 septembre 2025 Vranken-Pommery Monopole est entré en négociation exclusive avec Lanson-BCC, agissant pour le compte de sa filiale Maison Burtin, en vue de la cession des titres de la société Heidsieck & Co Monopole (propriétaire de la marque éponyme) à l’exclusion de tout autre actif. Sous conditions suspensives de l’accord des Conseils d’Administration des deux Maisons, le protocole devrait être signé le 1er octobre 2025. A propos de Vranken-Pommery Monopole : Vranken-Pommery Monopole gère 2 600 hectares en propriété...
Philips intends to extend maturity of forward purchases of 4 million shares for long-term incentive plans September 15, 2025 Amsterdam, the Netherlands – (NYSE: PHG, AEX: PHIA) announces today that it intends to extend the settlement of two forward contracts for 2 million long-term incentive plans shares each as part of the share repurchase program on June 14, 2023. The planned extension will postpone the original maturity dates in Q4 2025 by one year to a new maturity date in Q4 2026. Further details will be available via this . For further information, please contact:Michael FuchsPhil...
Statement of the number of actions and voting rights in 19.06.30 September 12th, 2025 Monthly publication of the number of shares comprising the share capital and the total number of voting rights(Articles L. 233-8 of the French Commercial Code and 223-16 of the AMF General Regulations) Stop date of information Total number of shares forming the share capital Total number of voting rightsAugust 31th, 20258.937.085Gross total voting rights: 15.435.792Net* total voting rights: 15.385.681 * Net total = total number of voting rights attached to shares - shares depri...
VRANKEN-POMMERY MONOPOLE : nombre total de droits de vote et d'actions au 30.06.2019 Le 12 septembre 2025 Publication mensuelledu nombre d’actions composant le capital et du nombre total de droits de vote(articles L.233-8 du Code commerce et 223-16 du Règlement général de l’AMF) Date d’arrêt des informationsNombre total d’actions composant le capital Nombre total des droits de vote 31 août 20258.937.085Total brut des droits de vote : 15.435.792Total net* des droits de vote : 15.385.681 * Total net = nombre total de droits de vote attachés aux actions - ac...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.